Nova Metabolic

The Nova Metabolic kit combines the incretin-research benchmark with two lipolytic fragments: Semaglutide, the GLP-1 analogue used as a reference in satiety and glucose-homeostasis studies; AOD-9604, the modified C-terminal fragment of growth hormone, studied in lipid metabolism without IGF-axis effects; and HGH Fragment 176-191, the original lipolytic sequence, examined in fat-oxidation models. The set covers the two major directions of body-weight research — central appetite regulation through incretin pathways and peripheral lipid mobilisation — enabling protocols that compare or combine them within the same experimental model. Product intended exclusively for laboratory research (Research Use Only). Not for human or veterinary use.